Oxford Biomedica changes name to OXB and strengthens transformation into leading global cell and gene therapy CDMO

Posted on September 18, 2024 by Vaseline

Oxford Biomedica changes name to OXB and strengthens transformation into leading global cell and gene therapy CDMO

Oxford, UK – September 18, 2024: OXB (LSE:OXB), a CDMO focused on quality and innovation in cell and gene therapy, today announces the launch of its new corporate brand.

Related Posts

US-Wahl: Look at the German Wohlstand at stake

Berlin has a lot of love for men, there are few people – two Italian people in the German mainland are proud of each other’s love

Ganzer Tag 20 to 0 hours 0 to 5 hours 5 to 8 hours 8 to 14 hours 14 to 20 hours